Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jan 15;70(2):792-801.
doi: 10.1158/0008-5472.CAN-09-3166. Epub 2010 Jan 12.

Matrix metalloproteinase-9 functions as a tumor suppressor in colitis-associated cancer

Affiliations

Matrix metalloproteinase-9 functions as a tumor suppressor in colitis-associated cancer

Pallavi Garg et al. Cancer Res. .

Abstract

There is a well-documented association of matrix metalloproteinase-9 (MMP-9) and receptor Notch-1 overexpression in colon cancer. We recently showed that MMP-9 is also upregulated in colitis, where it modulates tissue damage and goblet cell differentiation via proteolytic cleavage of Notch-1. In this study, we investigated whether MMP-9 is critical for colitis-associated colon cancer (CAC). Mice that are wild type (WT) or MMP-9 nullizygous (MMP-9(-/-)) were used for in vivo studies and the human enterocyte cell line Caco2-BBE was used for in vitro studies. CAC was induced in mice using an established carcinogenesis protocol that involves exposure to azoxymethane followed by treatment with dextran sodium sulfate. MMP-9(-/-) mice exhibited increased susceptibility to CAC relative to WT mice. Elevations in tumor multiplicity, size, and mortality were associated with increased proliferation and decreased apoptosis. Tumors formed in MMP-9(-/-) mice exhibited expression of p21(WAF1/Cip1) and increased expression of beta-catenin relative to WT mice. In vitro studies of MMP-9 overexpression showed increased Notch-1 activation with a reciprocal decrease in beta-catenin. Notch and beta-catenin/Wnt signaling have crucial roles in determining differentiation and carcinogenesis in gut epithelia. Despite being a mediator of proinflammatory responses in colitis, MMP-9 plays a protective role and acts as a tumor suppressor in CAC by modulating Notch-1 activation, thereby resulting in activation of p21(WAF1/Cip1) and suppression of beta-catenin.

PubMed Disclaimer

Figures

Figure 1
Figure 1
MMP-9 is highly expressed in CAC and MMP-9-/- mice show increased susceptibility to CAC. WT and MMP-9-/- mice (mice, n= 6 each group) were treated once with AOM and twice with 3% DSS to induce CAC. Mice were weighed once a week and were sacrificed after 56 days. 1A: western blot of proteins from the mucosal stripping of the colons of WT and MMP-9-/- mice with and without CAC probed with anti-MMP-9. Each lane shows protein (30μg/lane) from an individual mouse with or without CAC induction. Western blots were quantitated by scanning densitometry. Values are representative of three experiments, each bar represents mean ± S.E., *p<0.05. 1B: change in body weight of WT and MMP-9-/- mice (mice, n= 10 each group). 1C: inflammatory score, 1D(i): polyps count and 1D(ii): size of the polyp measured in diameter as described in the Methods section. Each bar represents mean ± S.E., *p< 0.05.
Figure 2
Figure 2
MMP-9-/- mice show increased susceptibility to CAC and mortality. Mortality studies were done as described in the Methods section. 2A: shows the mortality among WT and MMP-9-/- mice induced with CAC and followed for a total of 140 days or were sacrificed if they developed rectal prolapse and/or ≥20% body weight loss. 2B: polyps count and 2C: size of the polyp measured in diameter as described in the Methods section. Each bar represents mean ± S.E., *p< 0.05. 2D: representative gross anatomy of the colon of the MMP-9-/- mice and WT mice reflecting the number of polyps among them.
Figure 3
Figure 3
CAC in MMP-9-/- is associated with increased proliferation and decreased apoptosis. WT and MMP-9-/- mice (mice, n= 6 each group) with induced CAC and sacrificed after 56 days. Colon of the mice was processed for immunohistochemistry using anti-Ki67 antibody as described in the Methods section. 3A: representative sections of MMP-9-/- and WT mice with induced CAC. Proliferating cells are indicated by brown nuclei of the crypts with a counter staining of hematoxylin. 3B: graphs representing the number of nuclei positive for Ki67 staining per crypt. Each bar represents mean ± S.E., *p<0.05. 3C: shows the western blot of protein from the mucosal stripping of the colons of WT and MMP-9-/- with and without induction of CAC probed with anti-pCNA. Each lane shows protein (30μg/lane) from an individual mouse. Western blots were quantified by scanning densitometry and densities of MMP-9-/- mice relative to WT mice both induced with CAC are graphed adjacently.
Figure 4
Figure 4
A: TUNEL and DAPI staining and apoptotic cells in the right panel. 4B: represents the western blot of whole tissue lysates of the colons of WT and MMP-9-/- mice with and without CAC induction probed with anti-caspase-3. Each lane shows protein (30μg/lane) from an individual mouse. Adjacent graph shows the quantification of Western blots by scanning densitometry and plotting the densities of MMP-9-/- mice relative to WT mice both induced with CAC. Values are representative of three experiments, mean ± SE; *p<0.05.
Figure 5
Figure 5
CAC in MMP-9-/- mice showed altered protein expressions of p21WAF1/Cip1, β-catenin, NF-κB, COX-2 and i-NOS. WT and MMP-9-/- mice (mice, n= 6 each group) induced with CAC were sacrificed after 56 days. Each lane shows protein (30μg/lane) from an individual mouse with or without induction of CAC. 5A(i-iii): western blots of protein from the mucosal stripping of the colons of WT and MMP-9-/- mice with and without CAC induction probed with anti-p21WAF1/Cip1, anti- β-catenin and anti- NF-κB respectively. Adjacent graphs show the quantification by scanning densitometry. 5B(i-ii): western blots of protein from the mucosal stripping of the colons of WT and MMP-9-/- mice with and without induction of CAC probed with anti-COX-2 and anti-i-NOS respectively. Western blots were quantitated by scanning densitometry and graphed adjacently. Values are representative of three experiments, each bar represents mean ± S.E., *p<0.05.
Figure 6
Figure 6
MMP-9 overexpression results in altered levels of NICD, β-catenin, COX-2 and i-NOS. Caco2-BBE cells stably transfected with a pEGFP plasmid, with or without the MMP-9 gene were plated on 6 well filters at confluency and cell lysates were collected and immunoblotted for 6A(i): MMP-9, 6A(ii): NICD, 6A(iii): β-catenin, 6B(i): COX-2 and 6B(ii): i-NOS. β-tubulin was used as the loading control. Western blots were quantitated by scanning densitometry and graphed adjacently. Each lane shows protein (30μg/lane). Values are representative of three experiments, mean ± SE; *p<0.05.

Similar articles

Cited by

References

    1. Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer. 2002;2:161–74. - PubMed
    1. Okamoto R, Watanabe M. Cellular and molecular mechanisms of the epithelial repair in IBD. Dig Dis Sci. 2005;50(Suppl 1):S34–8. - PubMed
    1. Overall CM. Dilating the degradome: matrix metalloproteinase 2 (MMP-2) cuts to the heart of the matter. Biochem J. 2004;383:e5–7. - PMC - PubMed
    1. Castaneda FE, Walia B, Vijay-Kumar M, et al. Targeted deletion of metalloproteinase 9 attenuates experimental colitis in mice: central role of epithelial-derived MMP. Gastroenterology. 2005;129:1991–2008. - PubMed
    1. Baugh MD, Perry MJ, Hollander AP, et al. Matrix metalloproteinase levels are elevated in inflammatory bowel disease. Gastroenterology. 1999;117:814–22. - PubMed

Publication types

MeSH terms